Men's Health News

RSS

Research study to identify the appropriate amount of DHA required for promoting optimal heart health

A team of French scientists have found the dose of DHA (docosahexaenoic acid) that is "just right" for preventing cardiovascular disease in healthy men. In a research report appearing in the September 2009 print issue of The FASEB Journal, the scientists show that a 200 mg dose of DHA per day is enough to affect biochemical markers that reliably predict cardiovascular problems, such as those related to aging, atherosclerosis, and diabetes. This study is the first to identify how much DHA is necessary to promote optimal heart health.

1 Sep 2009

High incidence of HIV infection is found among South African gays

New research from UCSF examining HIV among men who have sex with men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

31 Aug 2009

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

DiagnoCure Inc. (TSX: CUR) announced that Gen-Probe, Inc. (NASDAQ: GPRO), its partner for the development and commercialization of the PCA3 prostate cancer test, has confirmed today the beginning of a U.S. clinical study intended to secure U.S. regulatory approval of the PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.

28 Aug 2009

Movember to present at the LIVESTRONG Global Cancer Summit

Staggering statistic: cancer kills more people every year than AIDS, tuberculosis and malaria combined. Joining more than 250 advocates from around the world, Adam Garone, co-founder and CEO of Movember, the world's largest charity for men's health, will present at the LIVESTRONG Global Cancer Summit in Dublin, Ireland, August 24 - 26.

27 Aug 2009

Rizer XL's male enhancement formula increases sexual desire, pleasure and performance

Increasing pressure on men to perform sexually and higher expectations of men's sexual performance from women has led to an astounding rise in sales, says Rizer XL, the leading provider of premium male enhancement pills.

27 Aug 2009

Cannabis chemicals halt prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer.

26 Aug 2009

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to a study in the August 26 issue of JAMA.

26 Aug 2009

Studies reveal that obese men are at increased risk for erectile dysfunction

Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Inc.

25 Aug 2009

Capital Earnings & Research to launch prostate cancer awareness campaign

What did all the following businessmen have in common?

24 Aug 2009

Cannabis chemicals stop prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer today.

21 Aug 2009

Results of PCF funded study could impact the standard of care for prostate cancer patients

Twice-yearly intravenous infusion with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. The report from an international research study, the first to document reduced fracture risk in men receiving the hormone-blocking treatment, was published today in the print edition of the New England Journal of Medicine (NEJM). Both fundamental research on rank ligand (RANKL) in prostate cancer bone metastasis and other molecular factors involved in the denosumab study were supported at Massachusetts General Hospital with funding from the Prostate Cancer Foundation (PCF).

21 Aug 2009

Obesity leads to worse prostate cancer in both black and whites equally

A new look at a large database of prostate cancer patients shows that obesity plays no favorites when it comes to increasing the risk of recurrence after surgery: Being way overweight is equally bad for blacks and whites, say researchers at Duke University Medical Center.

13 Aug 2009

$Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer$

Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer

Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer.

11 Aug 2009

Only the best looking men tempt women into casual sex

Men are far more interested in casual sex than women. While men need to be exceptionally attractive to tempt women to consider casual sex, men are far less choosy. These findings by Dr Achim Schützwohl, from the Department of Psychology at Brunel University in the UK, and his team are published online in Springer's journal Human Nature.

11 Aug 2009

Importance of PSA testing in high-risk men, stressed by National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Prostate Cancer Early Detection incorporating the results of the recent ERSPC trial that assessed the benefit of PSA screening. The NCCN Guidelines contend that PSA screening does save lives when performed intelligently in men at high-risk of developing the disease.

11 Aug 2009

Bob Monkhouse on a Twitter campaign for prostate cancer awareness

Bob Monkhouse, who was brought back to life by The Communications Agency to raise awareness (and a few bob) for the Prostate Cancer Research Foundation, is now twittering from beyond the grave.

10 Aug 2009

Seed implants suitable prostate cancer treatment for men of all ages

Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient.

3 Aug 2009

Epigenetic signature changes in low oxygen levels may contribute to prostate cancer development

UCD Conway researchers have characterised epigenetic signature changes in prostate cells under conditions of low oxygen levels that may lead to tumour development.

30 Jul 2009

Study finds few patients die from prostate cancer within 15 years of radical prostatectomy

Investigators at Memorial Sloan-Kettering Cancer Center (MSKCC), along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed the first large- scale, multi-institutional study of prostate cancer death after standard treatment to remove the prostate since PSA screening has become widely used as a method to screen for the disease.

28 Jul 2009

University at Buffalo start-up provides innovative digital sperm analysis to infertile couples worldwide

Couples struggling with fertility problems have a new option for assessing their ability to have a child with the start-up of a new Buffalo-based company called LifeCell Dx, Inc. (LCDX).

27 Jul 2009

Men's Health News

Research study to identify the appropriate amount of DHA required for promoting optimal heart health

High incidence of HIV infection is found among South African gays

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

Movember to present at the LIVESTRONG Global Cancer Summit

Rizer XL's male enhancement formula increases sexual desire, pleasure and performance

Cannabis chemicals halt prostate cancer growth

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

Studies reveal that obese men are at increased risk for erectile dysfunction

Capital Earnings & Research to launch prostate cancer awareness campaign

Cannabis chemicals stop prostate cancer growth

Results of PCF funded study could impact the standard of care for prostate cancer patients

Obesity leads to worse prostate cancer in both black and whites equally

Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer

Only the best looking men tempt women into casual sex

Importance of PSA testing in high-risk men, stressed by National Comprehensive Cancer Network

Bob Monkhouse on a Twitter campaign for prostate cancer awareness

Seed implants suitable prostate cancer treatment for men of all ages

Epigenetic signature changes in low oxygen levels may contribute to prostate cancer development

Study finds few patients die from prostate cancer within 15 years of radical prostatectomy

University at Buffalo start-up provides innovative digital sperm analysis to infertile couples worldwide

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News